Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Agilent Technologies and FDA Collaborate to Improve Testing for Salmonella

Published: Monday, March 26, 2012
Last Updated: Monday, March 26, 2012
Bookmark and Share
Project also seeks to develop better tools to test truth of seafood labels.

Agilent technologies announced that it has entered into a Cooperative Research and Development Agreement with the U.S. Food and Drug Administration to develop new tools to detect and analyze pathogens in food.

The joint R&D effort will also seek to improve DNA-based tools for confirming that seafood is correctly labeled.

The goal of the first part of the project is to develop a novel assay panel to identify subtypes of salmonella in food. When outbreaks occur, knowing the subtype can help officials quickly identify the source of the pathogen and hopefully limit the number of victims. The research will focus on using mass spectrometry-based genotyping to quickly identify salmonella subtypes.

"This effort on the part of Agilent is of extraordinary importance to the FDA," said Eric W. Brown, Ph.D, director, Division of Microbiology, FDA. "We expect this collaboration will be an important step in the development of new and specific tools for tracking bacterial pathogens in foods."

The second part of the agreement - to be carried out in collaboration with both the FDA and the Campden BRI laboratory in the United Kingdom - aims to update Agilent's lab-on-a-chip method of DNA analysis to identify fish species. Agilent's analytical technique can identify species even after the fish has been processed, which generally removes identifying features such as the head, tail and skin. The technology is based on the Agilent Bioanalyzer, using restriction fragment length polymorphism. The goal is to make this technology fast, inexpensive and simple enough that many kinds of laboratories can use it on a routine basis. This type of test could detect such things as intentional mislabeling to avoid tariffs and import restrictions or economic fraud where a less expensive species of fish is sold as a more costly species.

"We're very pleased to be collaborating with the FDA, because this work holds tremendous potential for solving some very challenging threats to the safety and integrity of the food supply," said Paul Zavitsanos, Agilent Global Food Safety manager. "There's real value in applying biological analysis techniques to food safety, and this collaboration advances our shared vision."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent’s 2014 Early Career Professor Award Supports Biomedical Research
Dr. Paul Blainey recognized for work in single-cell measurement, analysis.
Saturday, May 24, 2014
Agilent Technologies’ Exome Target-Enrichment System to Analyze 1,500 Samples in Erasmus Genetic Population Study
Erasmus Medical Center, Rotterdam, Netherlands, has selected the Agilent SureSelect XT Human All Exon target enrichment system along with the Agilent Bravo automated liquid-handling platform as part to identify genetic risk factors for some complex genetic disorders.
Thursday, March 08, 2012
Agilent and Monash University Sunway Campus Collaborate
Latest technologies to strengthen university’s investigations into diabetes, cancer, neurobiology and infectious diseases.
Friday, December 09, 2011
Agilent and Oxford Gene Technology Expand Partnership
Agilent to provide OGT with oligonucleotide microarrays and SureSelect target enrichment products for sequencing.
Tuesday, October 18, 2011
Agilent Appoints Molecular Genomics as its First Certified Service Provider for Microarrays in Singapore
Molecular Genomics offers microarray services using the Agilent CGH/SNP microarrays, gene expression, and microRNA products.
Monday, July 25, 2011
Agilent Appoints NIMGenetics as Spain’s First Certified Service Provider for CGH and CGH/SNP Microarrays
NIMGenetics has achieved CSP status for genomic research using Agilent SurePrint comparative genomic hybridization and CGH/SNP microarrays.
Thursday, May 19, 2011
Agilent Appoints Beckman Coulter Genomics First CSP for Target Enrichment and Microarrays
Beckman now is certified to perform SureSelect target enrichment upstream of both the AB SOLiD and Illumina Genome Analyzer sequencers.
Monday, November 08, 2010
Agilent Technologies’ Microfluidics System Used in Breakthrough Breast Milk Study
Company’s HPLC-Chip and QTOF LC/MS technology provided researchers a new view of the oligosaccharide structures produced in breast milk.
Wednesday, August 18, 2010
Agilent Technologies Extends Million-Feature Format to Gene Expression Microarrays
Agilent SurePrint G3 Gene Expression Microarrays provides up to one million features per standard 1-by-3-inch slide for added throughput.
Tuesday, May 18, 2010
Agilent Microarray Manufacturing Achieves ISO 13485 Compliance; Cytogenetics Platform Poised to Pursue FDA 510(k) Clearance
Agilent Technologies Inc. today announced that its entire portfolio of DNA microarrays is now manufactured under ISO 13485 certification, an internationally recognized standard for quality management systems (QMS).
Thursday, March 25, 2010
Agilent Technologies Announces New Leadership in Biological Systems Division
Company appoints Robert Schueren as VP and GM of Genomics; and John Fjeldsted, Ph.D., as GM of LC/MS.
Wednesday, February 17, 2010
Institute for Systems Biology, Agilent Technologies to Build MRM Atlas for Quantification of All Human Proteins
The project is expected to fuel important research gains in biomarker discovery and validation, personalized medicine, and human health monitoring.
Monday, October 26, 2009
Dolan DNA Learning Center Adopts Agilent Lab-on-a-Chip System to Teach DNA Techniques
CSHL’s learning center adopts the Agilent 2100 Bioanalyzer system to teach high school students and teachers how to analyze DNA.
Friday, August 14, 2009
Agilent Technologies’ Custom-Designed CGH Microarray Used to Map Korean Genome
Scientists using an Agilent custom-designed comparative genomic hybridization array have sequenced the entire gene map of a Korean male.
Wednesday, July 22, 2009
Phytronix and Agilent to Co-Market Phytronix LDTD Ion Source with Agilent Mass Spectrometers
The non-exclusive co-marketing agreement aims to promote the Phytronix Laser Diode Thermal Desorption Ion Source with Agilent mass spectrometers.
Wednesday, June 10, 2009
Scientific News
Paving the way to Better Ovarian Cancer Diagnosis
Aïcha BenTaieb will present her invention for automated identification of ovarian cancer’s many subtypes at an international conference this fall.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Futuristic Brain Probe Allows for Wireless Control of Neurons
NIH-funded scientists developed an ultra-thin, minimally invasive device for controlling brain cells with drugs and light.
Microfluidic Device Mixes And Matches DNA For Synthetic Biology
Researchers have developed a microfluidic device that quickly builds packages of DNA and delivers them into bacteria or yeast for further testing.
Artificial Pancreas Controls Diabetes
Scientists are reporting the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar, or glucose, level and can automatically release insulin as needed.
Major Step for Implantable Drug-Delivery Device
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.
Smart Insulin Patch Could Replace Painful Injections for Diabetes
A joint effort between diabetes doctors and biomedical engineers could revolutionize how people with diabetes keep their blood sugar levels in check.
The Secrets of Secretion
Researchers have hacked nature's blueprints to create a new technology that could have broad-reaching impact on drug delivery systems and self-healing and anti-fouling materials.
New Tool on Horizon for Surgeons Treating Cancer Patients
Surgeons could know while their patients are still on the operating table if a tissue is cancerous, according to researchers.
Heartbeat on a Chip Could Improve Pharmaceutical Tests
A gravity-powered chip that can mimic a human heartbeat outside the body could advance pharmaceutical testing and open new possibilities in cell culture because it can mimic fundamental physical rhythms.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!